Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

1,472 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma trial results

Active, Not Recruiting

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

NCT05109728

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Col Uni Med Center New York Presby New York, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • MD Anderson Cancer Center Uni of Te Houston, Texas, United States
  • University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

NCT03423628

Conditions
Astrocytoma, Behavior, Brain Diseases, +31 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

NCT03115333

Conditions
Astrocytoma, Glioblastoma, Glioma, +9 more
Locations
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Eden Hospital Medical Center Castro Valley, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

NCT03581292

Conditions
Anaplastic Astrocytoma, Astrocytoma, Glioblastoma, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 163 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

NCT02704858

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Sutter Health Research Institute San Francisco, California, United States
  • Saint John Cancer Institute Santa Monica, California, United States
  • Georgia Cancer Center (Augusta University) Augusta, Georgia, United States
View Trial Details
Active, Not Recruiting

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

NCT03919071

Conditions
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Anaplastic Ganglioglioma, +14 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 131 locations
View Trial Details
Active, Not Recruiting

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

NCT04485949

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Tufts Medical Center Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

NCT03212274

Conditions
Adenocarcinoma, Advanced Malignant Solid Neoplasm, Astrocytoma, +16 more
Locations
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
View all 51 locations
View Trial Details

Related conditions